Getwell Pharma India Private Limited — Etoposide Exporter Profile
Indian Pharmaceutical Exporter · #12 for Etoposide · $96.1K export value · DGFT Verified
Getwell Pharma India Private Limited is the #12 Indian exporter of Etoposide with $96.1K in export value and 23 verified shipments. Getwell Pharma India Private Limited holds a 0.9% market share in Etoposide exports across 6 countries. The company exports 10 pharmaceutical products worth $4.6M across 3 therapeutic categories.
Getwell Pharma India Private Limited — Etoposide Export Profile: Buyers & Destinations
Where Does Getwell Pharma India Private Limited Export Etoposide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $154.2K | 18 | 66.4% |
| SRI LANKA | $47.6K | 6 | 20.5% |
| NEPAL | $9.4K | 6 | 4.0% |
| JAMAICA | $7.1K | 8 | 3.1% |
| DOMINICAN REPUBLIC | $4.4K | 2 | 1.9% |
| TRINIDAD AND TOBAGO | $2.6K | 2 | 1.1% |
| PANAMA | $2.2K | 1 | 0.9% |
| MAURITIUS | $1.3K | 8 | 0.5% |
| GUYANA | $1.2K | 1 | 0.5% |
| KENYA | $1.1K | 4 | 0.5% |
Getwell Pharma India Private Limited exports Etoposide to 12 countries. The largest destination is PHILIPPINES accounting for 66.4% of Getwell Pharma India Private Limited's Etoposide shipments, followed by SRI LANKA (20.5%) and NEPAL (4.0%). These destinations reflect Getwell Pharma India Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Etoposide from Getwell Pharma India Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AGB PHARMACEUTICAL TRADING AND | PHILIPPINES | $99.3K | 10 |
| AGB PHARMACEUTICAL TRADING AND CONS | PHILIPPINES | $45.8K | 7 |
| THE ESSES PHARMACY(PRIVATE) LIMITED | SRI LANKA | $28.0K | 2 |
| THE ESSES PHARMACY (PRIVATE) LIMITE | SRI LANKA | $14.0K | 3 |
| AGB PHARMACEUTICAL TRADING AND CONSULTANCY CORPORATION | PHILIPPINES | $9.1K | 1 |
| RECHARGED DISTRIBUTORS LIMITED | JAMAICA | $7.1K | 8 |
| VISION CARE INTERNATIONAL PVT. LTD. | NEPAL | $7.1K | 5 |
| THE ESSES PHARMACY (PRIVATE)LIMITED | SRI LANKA | $5.6K | 1 |
| CAPIS MEDICAL SA | DOMINICAN REPUBLIC | $4.4K | 2 |
| SUNCREST INTERNATIONAL LIMITED | TRINIDAD AND TOBAGO | $2.6K | 1 |
Getwell Pharma India Private Limited supplies Etoposide to 22 buyers globally. The largest buyer is AGB PHARMACEUTICAL TRADING AND (PHILIPPINES), followed by AGB PHARMACEUTICAL TRADING AND CONS (PHILIPPINES) and THE ESSES PHARMACY(PRIVATE) LIMITED (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Etoposide Export Value and How Much Does Getwell Pharma India Private Limited Contribute?
India exported $9.5M worth of Etoposide through 2,129 shipments from 237 suppliers to 122 countries, serving 598 buyers globally. Getwell Pharma India Private Limited contributes $96.1K to this total, accounting for 0.9% of India's Etoposide exports. Getwell Pharma India Private Limited ships Etoposide to 12 countries through 22 buyers.
What Is the Average Shipment Value for Getwell Pharma India Private Limited's Etoposide Exports?
Getwell Pharma India Private Limited's average Etoposide shipment value is $4.2K per consignment, based on 23 shipments totaling $96.1K. The largest destination is PHILIPPINES (66.4% of Getwell Pharma India Private Limited's Etoposide exports).
How Does Getwell Pharma India Private Limited Compare to Other Indian Etoposide Exporters?
Getwell Pharma India Private Limited ranks #12 among 237 Indian Etoposide exporters with a 0.9% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($4.8M), FRESENIUS KABI ONCOLOGY LIMITED ($1.9M), VENUS REMEDIES LIMITED ($988.8K). Getwell Pharma India Private Limited processed 23 shipments to 6 destination countries.
What Etoposide Formulations Does Getwell Pharma India Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ETOPA 100MG/5ML (ETOPOSIDE INJECTION USP | $96.4K | 24 |
| ETOPA 100MG/5ML (ETOPOSIDE INJECTION USP)BATCH NO. 4GET01, MFG.DT. 02/2024, EXP.DT. 01/2026 | $15.8K | 1 |
| ETOPA 100MG/5ML (ETOPOSIDE INJECTION USP) BATCH NO. 5GET02, MFG.DT. 01/2025, EXP.DT. 12/2026 | $12.7K | 1 |
| ETOPOJECT 100MG/5ML (ETOPOSIDE INJECTIONUSP) BATCH NO. 4GET03, MFG.DT. 06/2024,EXP.DT. 05/2026 | $10.6K | 1 |
| ETOPOJECT 100MG/5ML (ETOPOSIDE INJECTION USP)BATCH NO. 4GET02, MFG.DT. 02/2024, EXP.DT. 01/2026 | $10.3K | 1 |
| ETOPOJECT 100MG/5ML (ETOPOSIDE INJECTIONUSP)BATCH NO.5GET01, MFG.DT. 01/2025, EXP.DT. 12/2026 | $10.2K | 1 |
| ETOPOJECT 100MG/5ML ETOPOSIDE INJECTIONUSP BATCH NO. 3GET06 MANUFACTURING .DT. 07/2023EXP.DT. 06/2025 | $9.1K | 1 |
| ETOPOJECT 100MG/5ML (ETOPOSIDE INJECTIONUSP) BATCH NO. 3GET08, MFG.DT. 12/2023,EXP.DT. 11/2025NOS | $8.8K | 3 |
| ETOPA 100MG/5ML (ETOPOSIDE INJECTION USP) BATCH NO. 3GET07, MFG.DT. 11/2023,EXP.DT. 10/2025NOS | $8.8K | 1 |
| ETOPOJECT 100MG 5ML ETOPOSIDE INJECTION USP BATCH NO 3GET02 MFG DT 02 2023 EXP DT 01 2025 | $8.7K | 1 |
Getwell Pharma India Private Limited exports 28 distinct Etoposide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ETOPA 100MG/5ML (ETOPOSIDE INJECTION USP with 24 shipments worth $96.4K.
How Does Getwell Pharma India Private Limited Compare to Nearest Etoposide Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | KHANDELWAL LABORATORIES PRIVATE LIMITED | $98.1K | 14 | 5 | $7.0K |
| 11 | BETA DRUGS LIMITED | $96.4K | 58 | 8 | $1.7K |
| 12 | GETWELL PHARMA INDIA PRIVATE LIMITED ★ | $96.1K | 23 | 6 | $4.2K |
| 13 | UNITED BIOTECH PRIVATE LIMITED | $65.9K | 37 | 10 | $1.8K |
| 14 | RUS MED EXPORTS PVT. LTD. | $48.0K | 3 | 1 | $16.0K |
Getwell Pharma India Private Limited ranks #12 among 237 Indian Etoposide exporters. Average shipment value of $4.2K compared to the market average of $40.3K. The closest competitors by value are KHANDELWAL LABORATORIES PRIVATE LIMITED and BETA DRUGS LIMITED.
Which Indian Ports Ship Etoposide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 357 | 16.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 333 | 15.6% |
| DELHI AIR | 258 | 12.1% |
| DELHI AIR CARGO ACC (INDEL4) | 244 | 11.5% |
| AHEMDABAD AIR ACC (INAMD4) | 141 | 6.6% |
| AHEMDABAD AIR | 135 | 6.3% |
| MUNDRA SEA (INMUN1) | 129 | 6.1% |
| Bombay Air | 96 | 4.5% |
What Other Oncology Products Does Getwell Pharma India Private Limited Export?
Getwell Pharma India Private Limited also exports these oncology products. Each links to the detailed product page.
About Getwell Pharma India Private Limited
Getwell Pharma India Private Limited exports 10 products worth $4.6M. Beyond Etoposide, top products include Paclitaxel, Protein, Doxorubicin, Gemcitabine, Fluorouracil. View the complete Getwell Pharma India Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Etoposide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Etoposide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Getwell Pharma India Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 58 individual customs records matching Getwell Pharma India Private Limited exporting Etoposide, covering 28 formulations to 12 countries via 22 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 598+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Etoposide Export Data from Getwell Pharma India Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Getwell Pharma India Private Limited's Etoposide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Getwell Pharma India Private Limited
Full Company Profile →
10 products · $4.6M total trade · 3 categories
Etoposide Stats
Company Overview
Top Products by Getwell Pharma India Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Getwell Pharma India Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Etoposide. For current shipment-level data, contact TransData Nexus.